Article Information
- Received April 8, 2003
- Revision received May 27, 2003
- Accepted July 14, 2003
- First published September 3, 2003.
- Version of record published September 3, 2003.
Author Information
- Mara Bresjanac1,2,
- Lojze M. Smid1,2,
- Tomaz D. Vovko1,2,
- Andrej Petrič3,
- Jorge R. Barrio4, and
- Mara Popovic2
- 1Laboratory for Neuronal Plasticity and Regeneration, Institute of Pathophysiology, 2Prion Laboratory, Institute of Pathology, School of Medicine, and 3Faculty of Chemistry and Chemical Technology, University of Ljubljana, SI-1000 Ljubljana, Slovenia, and 4Division of Nuclear Medicine, Department of Molecular and Medical Pharmacology, Laboratory of Structural Biology and Molecular Medicine, University of California, Los Angeles, School of Medicine, Los Angeles, California 90095
Author contributions
Disclosures
- Received April 8, 2003.
- Revision received May 27, 2003.
- Accepted July 14, 2003.
This work was supported by the Republic of Slovenia Ministry of Health; Ministry of Education, Science and Sport Grants 0381-518, L3-3435 (M.B. and M.P.), P0-503-0103, and Slo-US 2001/34 (A.P.); and the European Union-funded project “Human Transmissible Spongiform Encephalopathies: The Neuropathology Network (PRIONET)” (M.P.). We acknowledge the assistance of Dr. Herbert Budka (Institute of Neurology, University of Vienna, and Austrian Reference Centre for Human Prion Diseases, Vienna, Austria) and Dr. James Ironside (Neuropathology Laboratory, CJD Surveillance Unit, University of Edinburgh, Edinburgh, UK), who kindly provided the samples of GSS and vCJD cerebellar tissue.
Correspondence should be addressed to Dr. Mara Bresjanac, Institute of Pathophysiology, Zaloska 4, SI-1000 Ljubljana, Slovenia. E-mail: maja.bresjanac{at}mf.uni-lj.si.
Copyright © 2003 Society for Neuroscience 0270-6474/03/238029-05$15.00/0
Online Impact
Article usage
In this issue
